Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT)

CUSIP: 03969T109

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
28,412,394
Total 13F shares
21,454,944
Share change
+1,493,796
Total reported value
$578,272,039
Put/Call ratio
44%
Price per share
$26.96
Number of holders
122
Value change
+$36,976,142
Number of buys
52
Number of sells
64

Quarterly Holders Quick Answers

What is CUSIP 03969T109?
CUSIP 03969T109 identifies ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) as of Q1 2022

As of 31 Mar 2022, Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) was held by 122 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,454,944 shares. The largest 10 holders included FEDERATED HERMES, INC., STATE STREET CORP, ARK Investment Management LLC, BlackRock Inc., Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., VANGUARD GROUP INC, FMR LLC, Point72 Asset Management, L.P., and GEODE CAPITAL MANAGEMENT, LLC. This page lists 122 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.